In this webinar, KDIGO 2024 ANCA Vasculitis Guideline Co-Chair Brad Rovin, MD (United States), and Geetha Duvuru, MD (United States) review the latest KDIGO guidance using case-based studies, including a discussion on indications for plasma exchange and avacopan, to showcase challenging patient scenarios and illustrate the optimal application of guideline recommendations and practice points.
Topics addressed in this webinar include:
• Optimal treatment in patients with refractory disease
• Appropriate management in patients with relapsing disease
• Ideal approach in patients with organ/life-threatening disease
• Management of AAV in the kidney transplant population
This webinar originally took place on May 30, 2024. This was supported by Amgen.